Available Formats
Our Future is Biotech: Understanding and profiting from the next tech revolution
By (Author) Andrew Craig
John Murray Press
John Murray Business
27th August 2024
United Kingdom
Tertiary Education
Non Fiction
Business and Management
Investment and securities
Science: general issues
Sociology
660.6
Paperback
272
Width 152mm, Height 232mm, Spine 24mm
340g
The Apples, Amazons and Googles of the next few decades will be biotech companies. The tech companies of the last few years have changed how we do things but the businesses driving the biotech revolution are about making life better. These companies will solve many of our most intractable problems: cancer, dementia, diabetes, elderly care, mental health challenges, even power generation and agricultural production. Biotech will mean that we can live far better, safer, healthier, wealthier, happier, and longer lives.
Very few people in the general population have any idea of the phenomenal progress being made in these areas. There are already "miracle cures" for several diseases with far more to come. Exponential progress will drive the price of such things down far enough to make them widely available globally. This goes a long way beyond just "healthcare". These technologies could be key to dealing with climate change and the destruction of the natural world.This is a landmark and important book by a biotech investment expert who has been working in the industry for the past 6.5 years and knows how biotech does and doesn't work. The book explains what biotech is, what is coming next, and how investors can profit from it.Andrew Craig is a best-selling finance author, Founder of personal finance website www.plainenglishfinance.com and Investment Manager of the VT PEF Global Multi-Asset Fund. From January 2015 to May 2021, he was a partner at an investment bank specialising in biotechnology and life sciences.
Andrew has worked for leading financial institutions since 1998. He began his finance career at SBC Warburg in the late nineties. Since then, he has held various senior equity roles at leading investment banks, both in London and New York. In that time, Andrew has met with the senior management teams of over one thousand companies and with several hundred professional investors and has regularly been involved in high profile stock market transactions. (These have included the Kingdom of Sweden's sales of Nordea Bank AB in 2013 (totalling $7.6 billion) and the stock market flotation of several dozen companies including the likes of: easyJet, Burberry,Campari, Carluccio's, the Carbon Trust and lastminute.com).Since founding Plain English Finance in 2011, Andrew has appeared in numerous national and specialist financial publications including: The Mail on Sunday, The Mirror, CityAM, The Spectator, Shares and MoneyWeek magazines, YourMoney, This Is Money and Money Observer. He has been interviewed on Bloomberg and Shares Radio and on IG TV, was featured in Russell Brand and Michael Winterbottom's 2015 film "The Emperor's New Clothes" and interviewed by Eamonn Holmes for the Channel 5 programme "How the other half live".